Clinical Trials

Phase 1/2 Active not recruiting

Colorectal Neoplasms

NCT05488314 2026-06-05

METalmark

57 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05498428 2026-06-05

PALOMA-2

Phase 2 Recruiting

520 enrolled

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05908734 2026-06-05

PolyDamas

71 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06120140 2026-06-05

COCOON

305 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06385080 2026-06-05

OrigAMI-4

Phase 1/2 Recruiting

287 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06662786 2026-06-05

OrigAMI-2

Phase 3 Recruiting

1,000 enrolled

Colorectal Neoplasms

NCT06667076 2026-06-05

COPERNICUS

Phase 2 Recruiting

480 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06750094 2026-06-05

OrigAMI-3

Phase 3 Recruiting

700 enrolled

Colorectal Neoplasms

NCT07227025 2026-06-05

KaRAnaSa

Phase 1/2 Recruiting

60 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07276399 2026-06-05

OrigAMI-5

Phase 3 Recruiting

500 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05663866 2026-06-02

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

68 enrolled 12 charts

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07586202 2026-05-14

AmiNA

68 enrolled

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04077463 2026-05-08

Chrysalis-2

701 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04487080 2026-05-08

MARIPOSA

1,074 enrolled 13 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT04538664 2026-05-08

PAPILLON

308 enrolled 12 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT04988295 2026-05-08

MARIPOSA-2

776 enrolled 13 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT05388669 2026-05-08

PALOMA-3

418 enrolled 16 charts

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung

NCT06816992 2026-04-24

ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC

Phase 1 Recruiting

76 enrolled

Solid Tumors

NCT06532032 2026-04-13

swalloWTail

Phase 1/2 Active not recruiting

12 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05801029 2026-03-20

OSTARA

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Phase 1 Recruiting

100 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04599712 2025-06-13

Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung Cancer

Approved for marketing

Carcinoma, Non-Small-Cell Lung

NCT05653427 2025-01-13

A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma

Phase 2 Terminated

18 enrolled 20 charts

Carcinoma, Hepatocellular

NCT04945733 2024-09-19

A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer

Phase 2 Terminated

62 enrolled 28 charts